CN101643732A - 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽 - Google Patents

在乳腺癌和膀胱癌中差异表达的基因及编码的多肽 Download PDF

Info

Publication number
CN101643732A
CN101643732A CN200910007590A CN200910007590A CN101643732A CN 101643732 A CN101643732 A CN 101643732A CN 200910007590 A CN200910007590 A CN 200910007590A CN 200910007590 A CN200910007590 A CN 200910007590A CN 101643732 A CN101643732 A CN 101643732A
Authority
CN
China
Prior art keywords
seq
polypeptide
polynucleotide
sequence
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910007590A
Other languages
English (en)
Chinese (zh)
Inventor
M·佐德尔
E·E·埃文斯
M·A·博雷罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of CN101643732A publication Critical patent/CN101643732A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN200910007590A 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽 Pending CN101643732A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19446300P 2000-04-04 2000-04-04
US60/194,463 2000-04-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA018178049A Division CN1610743A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽

Publications (1)

Publication Number Publication Date
CN101643732A true CN101643732A (zh) 2010-02-10

Family

ID=22717696

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200910007590A Pending CN101643732A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽
CNA018178049A Pending CN1610743A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA018178049A Pending CN1610743A (zh) 2000-04-04 2001-04-04 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽

Country Status (10)

Country Link
US (3) US7268207B2 (https=)
EP (1) EP1272636B8 (https=)
JP (1) JP2004502408A (https=)
CN (2) CN101643732A (https=)
AT (1) ATE404669T1 (https=)
AU (2) AU2001253119B2 (https=)
CA (1) CA2413211A1 (https=)
DE (1) DE60135315D1 (https=)
NZ (1) NZ522282A (https=)
WO (1) WO2001074859A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114868004A (zh) * 2019-10-18 2022-08-05 小利兰·斯坦福大学董事会 临床和工业规模的完整组织测序
CN115407064A (zh) * 2021-05-26 2022-11-29 复旦大学附属肿瘤医院 肿瘤干细胞血管拟态标志物tem8在制备诊断试剂和试剂盒中的用途
US12359253B2 (en) 2018-04-09 2025-07-15 The Board Of Trustees Of The Leland Stanford Junior University Method of in situ gene sequencing

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1272636B8 (en) 2000-04-04 2008-10-08 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US7135278B1 (en) 2000-09-29 2006-11-14 University Of Rochester Method of screening for therapeutics for infectious diseases
CA2438505A1 (en) * 2001-02-14 2002-09-12 Genzyme Corporation Altered peptide ligands
WO2003004989A2 (en) * 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2003274463B2 (en) 2002-06-10 2009-10-29 University Of Rochester Gene differentially expressed in breast and bladder cancer and encoded polypeptides
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
WO2004087058A2 (en) * 2003-03-28 2004-10-14 Vaccinex, Inc. Targeted mhc class i alpha3 vaccine delivery systems
WO2005099361A2 (en) * 2003-07-10 2005-10-27 Vaccinex, Inc. MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
AU2004296184B2 (en) * 2003-12-04 2010-12-16 Vaccinex, Inc. Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
US20050266425A1 (en) * 2003-12-31 2005-12-01 Vaccinex, Inc. Methods for producing and identifying multispecific antibodies
JP2007530075A (ja) * 2004-04-23 2007-11-01 エグザジェン ダイアグノスティクス インコーポレイテッド 乳がんの予後診断のための組成物および方法
AU2007261247A1 (en) * 2006-06-22 2007-12-27 Vaccinex, Inc. Anti-C35 antibodies for treating cancer
AU2008219020B2 (en) * 2007-02-21 2013-08-22 Vaccinex, Inc. Modulation of NKT cell activity with antigen-loaded CDId molecules
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
CA2710680C (en) 2007-12-26 2018-10-16 Vaccinex, Inc. Anti-c35 antibody combination therapies and methods
CN102325875B (zh) 2009-01-08 2018-04-10 阿尔伯爱因斯坦医学有限公司 具有细胞壁结合神经酰胺类糖脂的细菌疫苗及其应用
US8808693B2 (en) * 2009-04-01 2014-08-19 The University Of British Columbia Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses
EP2480563B1 (en) 2009-09-24 2017-02-22 The Regents of The University of California Bladder cancer specific ligand peptides
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
ES2970865T3 (es) * 2015-12-16 2024-05-31 Gritstone Bio Inc Identificación, fabricación y uso de neoantígenos
US20200363414A1 (en) * 2017-09-05 2020-11-19 Gritstone Oncology, Inc. Neoantigen Identification for T-Cell Therapy
EP4576103A3 (en) 2017-10-10 2025-08-27 Gritstone bio, Inc. Neoantigen identification using hotspots
CN111630602A (zh) 2017-11-22 2020-09-04 磨石肿瘤生物技术公司 减少新抗原的接合表位呈递
KR102318018B1 (ko) 2019-07-05 2021-10-28 한국생산기술연구원 마이크로 제품 제작용 맨드렐 제작 방법, 마이크로 제품 제작용 몰드 제작 방법 및 마이크로 제품 제작용 몰드
US20240409582A1 (en) * 2022-08-23 2024-12-12 The University of North Texas Health Sciences Cente Design and characterization of inhibitory peptides (ipeps) derived from of mien 1 protein sequence

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0581600A (ja) * 1991-04-18 1993-04-02 Fujitsu Ltd 双曲線航法システムにおけるシステム監視処理方式
WO1994003205A1 (en) 1992-08-07 1994-02-17 Cytel Corporation Hla binding peptides and their uses
BR9406652A (pt) 1993-03-05 1996-09-10 Cytel Corp Composição
US5856131A (en) * 1997-02-24 1999-01-05 Incyte Pharmaceuticals, Inc. Human selenoprotein
US7026447B2 (en) * 1997-10-09 2006-04-11 Human Genome Sciences, Inc. 53 human secreted proteins
WO1999033869A2 (en) * 1997-12-24 1999-07-08 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1999037775A2 (en) 1998-01-26 1999-07-29 Genquest, Inc. Compositions and methods for detecting and treating breast cancer
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1248800A2 (en) 1999-11-30 2002-10-16 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1272636B8 (en) * 2000-04-04 2008-10-08 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US20030166277A1 (en) 2000-04-12 2003-09-04 University Of Rochester Targeted vaccine delivery systems
AU2001297872B2 (en) * 2000-11-17 2006-11-09 University Of Rochester In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
AU2003274463B2 (en) 2002-06-10 2009-10-29 University Of Rochester Gene differentially expressed in breast and bladder cancer and encoded polypeptides
WO2005099361A2 (en) 2003-07-10 2005-10-27 Vaccinex, Inc. MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
AU2004296184B2 (en) * 2003-12-04 2010-12-16 Vaccinex, Inc. Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12359253B2 (en) 2018-04-09 2025-07-15 The Board Of Trustees Of The Leland Stanford Junior University Method of in situ gene sequencing
CN114868004A (zh) * 2019-10-18 2022-08-05 小利兰·斯坦福大学董事会 临床和工业规模的完整组织测序
CN115407064A (zh) * 2021-05-26 2022-11-29 复旦大学附属肿瘤医院 肿瘤干细胞血管拟态标志物tem8在制备诊断试剂和试剂盒中的用途

Also Published As

Publication number Publication date
NZ522282A (en) 2005-03-24
US20090312263A1 (en) 2009-12-17
DE60135315D1 (de) 2008-09-25
CN1610743A (zh) 2005-04-27
CA2413211A1 (en) 2001-10-11
WO2001074859A3 (en) 2002-03-28
US20070081942A1 (en) 2007-04-12
US20020155447A1 (en) 2002-10-24
EP1272636A2 (en) 2003-01-08
WO2001074859A2 (en) 2001-10-11
EP1272636B1 (en) 2008-08-13
JP2004502408A (ja) 2004-01-29
US7910551B2 (en) 2011-03-22
EP1272636B8 (en) 2008-10-08
US7268207B2 (en) 2007-09-11
AU2001253119B2 (en) 2006-04-13
AU5311901A (en) 2001-10-15
ATE404669T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
CN101643732A (zh) 在乳腺癌和膀胱癌中差异表达的基因及编码的多肽
US20040063907A1 (en) Gene differentially expressed in breast and bladder cancer and encoded polypeptides
AU2001253119A2 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US20020044941A1 (en) Nucleic acids, proteins and antibodies
NZ503404A (en) The presence of unique DNA and RNA molecules in prostate tumour cells and their use in diagnostic detection methods
WO1998045712A2 (en) 20 human secreted proteins
US6433139B1 (en) Secreted protein HPEAD48
US6806351B2 (en) Secreted protein HBJFE12
US20020183503A1 (en) 26 human secreted proteins
CN101173285A (zh) 在乳腺癌和膀胱癌中差异表达的基因及编码多肽
AU2006202984B2 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US20030028003A1 (en) 125 human secreted proteins
US20030054443A1 (en) 90 human secreted proteins
EP1788085A1 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
NZ548918A (en) Gene differentially expressed in breast and bladder cancer and encoded polypeptides

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100210